America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two ...
Supermarkets could be hit with penalties over junk food sales under new proposals to tackle obesity - The Health and Social ...
Government must ‘stand up to the food industry’ to tackle obesity epidemic – MPs - All outdoor advertising of junk food ...
A Lancet report listed the 14 dementia risk factors and how much they each matter at different stages of life, as well as ...
The headlines were everywhere – from NPR and The Washington Post to Substack and heated exchanges on social media – all circling the same claim: Ozempic might lower the risk of cancer. Behind those ...
With the rise of Ozempic and Wegovy, I find myself asking a question I wish I were above asking: Is getting thinner the goal ...
Research shows potential positive impacts of weight loss drugs.
The Hearty Soul on MSN
You may be one of the 90% of US adults who have a syndrome that most have never heard of
Nearly 90% of U.S. adults have at least one metabolic syndrome symptom linked to CKM syndrome - yet most have never heard of ...
The proportion of adults in the US taking GLP-1 medications for weight loss has reached a record high of about 40 million people.
A new systematic review and meta-analysis presented at the International Congress on Obesity (ICO2026), hosted by the World ...
A new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional ...
The 2025 US death rate was 4.6% lower than in 2024, while leading causes of death include heart disease, cancer, and unintentional injuries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results